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Edited by Felix WielandAbstract UDP-Gal:GA2/GM2/GD2/GT2 galactosyltransfer-
ase (Gal-T2) transfers galactose to the terminal N-acetylgalac-
tosamine of either the neutral glycolipid GA2 or of the
gangliosides GM2, GD2 and GT2. Previous studies revealed a
tight regulation of Gal-T2 activity and mRNA expression during
development of the rat CNS. Here, we study in PC12 cells the
cis-acting elements involved in the activation of a fragment of
211 bp around the transcription initiation site of the mouse Gal-
T2 promoter. Mutagenesis, competition experiments and func-
tional assays showed that the Ets-1 transcription factor is
involved in the activation of the Gal-T2 promoter.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Gangliosides play important roles in large variety of bio-
logical processes, such as cell–cell and cell–extracellular
matrix interactions, adhesion, cell diﬀerentiation, growth
control and receptor-mediated signal transduction [1,2].
Their synthesis is catalyzed by glycosyltransferases that act
in succession catalyzing the stepwise transfer of sugar to
growing glycolipid oligosaccharides [3–5]. UDP-Gal:GA2/
GM2/GD2/GT2 galactosyltransferase (Gal-T2) catalyzes the
transfer of galactose residues from the sugar nucleotide
donor UDP-Gal to the N-acetylgalactosamine residue of
either the neutral glycolipid GA2 or of the gangliosides
GM2, GD2 and GT2.
Mouse Gal-T2 is coded by one gene contained into a single
exon located in chromosome 17 [6], 500 bp downstream the
polyadenylation signal of the S18 ribosomal protein gene
(RPS18 gene). The locus contains a number of genes conserved
and synthenic in human, rat and mouse genome. Gal-T2 ac-
tivity and mRNA levels are developmentally regulated in the
rat CNS [6,7]. Gal-T2 mRNA is also highly expressed in adult
extraneural tissues, particularly testis, which also showed ele-
vated Gal-T2 activity [6]. Altogether, these results strongly
suggest that Gal-T2 is under transcriptional control both in
neural and extraneural tissues.* Corresponding author. Fax: +54-351-4334074.
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0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.09.066So far, scarce information is available on the mechanisms
involved in the transcriptional regulation of Gal-T2. Recently,
a 1142 bp 50 ﬂanking fragment of the mouse Gal-T2 gene with
promoter activity located at )550/+9 bp was characterized in
mouse neuroblastoma Neuro-2a cells; a combination of DNA
pull-down assay and transcription factor array analyses evi-
denced consensus sequences for the binding of 27 diﬀerent
transcription factors [8]. Here, we study in PC12 cells the cis-
acting elements involved in the activation of a fragment of 211
bp of the mouse Gal-T2 promoter. PC12 cells were used since
they express terminal galactose containing complex ganglio-
sides GM1, GD1a, GD1b and GT1b [9], and hence the tran-
scription factors required for Gal-T2 promoter activity.
Results revealed binding sites for Ets-1 transcription factors
surrounding the transcription start site. Mutagenesis, compe-
tition and overexpression experiments, and functional assays
showed that an Ets-1 binding site at )32/)23 bp is critical for
the activity of Gal-T2 promoter.2. Materials and methods
2.1. Plasmid constructs
Fragments )59/+152, )308/+38, )308/)9 and )465/+38 (nucleotide
positions are indicated with respect to the transcriptional start site [8])
were ampliﬁed by PCR from a 2 kb PCR fragment previously ampli-
ﬁed from DNA BAC425018 clone (AF110520) containing the entire
mouse Gal-T2 gene and cloned into the KpnI/XhoI sites of the pGL3
basic reporter plasmid (Promega). The primers used in PCRs are listed
in Table 1. Constructs identities were certiﬁed by sequencing. The
mouse Ets-1 expressing plasmid pEVRFO Ets-1 and empty pEVRFO
were kindly provided by P.K. Brindle, St. Jude Children Research
Hospital, Memphis, TN, USA.
2.2. Cell culture, transfection and luciferase assays
PC12 rat pheocromocitoma cells were grown as Gil et al. [10] and
transfected using LipofectAmine (Gibco-BRL) with 500 ng of each
promoter construct and 80 ng of phRL-SV40 renilla luciferase as a
control for transfection eﬃciency. Two days later, they were har-
vested with Passive Lysis Buﬀer (Promega). The relative ﬁreﬂy lu-
ciferase activity was normalized to the renilla luciferase activity
(Dual-Luciferase reporter assay system, Promega). For each condi-
tion, at least three independent experiments were performed in
triplicate.
2.3. Electrophoretic mobility shift assay
Total cell extracts were obtained from PC12 cells according to the
methods of Kumar and Chambon [11]. Twenty lg of total PC12
cell extract was incubated for 20 min on ice with 20 ll of reaction
buﬀer containing 20 mM Tris, pH 7.5, 2 mM DTT, 0.5 mM PMSF,ation of European Biochemical Societies.
Table 2
Oligonucleotides used for EMSA experiments
Designation Sequence
)44/)12 50 CACGCCGCTTGTCGGCTTCCGGCCTAGAGAGGC 30
44/)12 mEts-1 50 CACGCCGCTTGTCGGCAGATCTCCTAGAGAGGC 30
)8/+25 50 ATGGGAAGGTGCGGGGAGGGACGGGATGGAGCG 30
)8/+25 mSp1 50 ATGGGAAGGTGCGAAGCTTGACGGGATGGAGCG 30
GABP 50 GGGCTGCTTGAGGAAGTATAAGAAT 30
PEA3/Ets-1 50 GATCTCGAGCAGCAACTTCGA 30
Sp1 50 TTATTCGATCGGGGCGGGGCGAGC 30
c-Myc 50 GGAAGCAGACCACGTGGTCTGCTTCC 30
USF1 50 CACCCGGTCACGTGGCCTACACC 30
SRE 50 GGATGTCCATATTAGGACATCT 30
NF-1 50 TTTTGGATTGAAGCCAATATGATAA 30
TFIID 50 GCAGAGCATATAAGGTGAGGTAGGA 30
Oct-1 50 TGTCGAATG AAATCACTAGAA 30
NSI 50 GACCTATGTGAAATGCACGCCGCTTGTCGGCTT 30
NSII 50 CCGGCCTAGAGAGGCATGATGGGAAGGTGCGGG 30
Primers were annealed and 50 end labeled by incubation with c32P-ATP
and T4 polynucleotide kinase.
Table 1
Primer sequences used for PCR cloning
Designation Sequence
+152 Gal-T2 50 TCTCTCGAGACCCATGCGCGGGGCTCTGG 30
)9 Gal-T2 50 TCTCTCGAGCATGCCTCTCTAGGCCGGAA 30
+38 Gal-T2 50 TCTCTCGAGGCACGCGGAACTCCGCTCCATCCC 30
)59 Gal-T2 50 TCTGGTACCGACCTATGTGAAATGCACGCC 30
)308 Gal-T2 50 TCTGGTACCTGCCTTAGGTGCAGCAAACTGGGCGG 30
)465 Gal-T2 50 TCTGGTACCAGTACTTAATGCCACAGCGATCC 30
)109 Gal-T2 50 TCTGGTACCCAGCCTGGTATTCCGCG 30
)59 mEts 50 TCTGGTACCGACCTATGTGAAATGCACGCCGCTTGTCGGCAGATCTCCTAGAGAGGC 30
Underlined are restriction sites introduced at the 50 ends for further cloning.
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glycerol, and 1 lg salmon sperm DNA. The radiolabeled probes
(Table 2) were added (14000 cpm/pmol) and the incubation system
was continued for another 20 min. In competition experiments, the
nuclear extracts were pre-incubated during 20 min with the indi-
cated molar excess of unlabeled probe. DNA-protein complexesFig. 1. Deletion analysis and activity of Gal-T2 promoter. (A) PC12 cells were
promoter cloned in pGL3 basic vector. (B) Promoter activity of the DNA fra
activity.were analyzed on non-denaturing 5% polyacrylamide gels using 0.5·
TBE as running buﬀer. Oligonucleotides used as electrophoretic
mobility shift assay (EMSA) probes are listed in Table 2.
2.4. Site-directed mutagenesis
For mutation of Sp1 site, two sets of primary PCRs were run using
+152/)59 pGL3 plasmid as DNA template and the following pairs of
primers: )8/+25 mSp1 forward/+152 Gal-T2 and )8/+25 mSp1 re-
verse/)59 Gal-T2 (Tables 1 and 2). The secondary PCR was carried
out using the combined gel-puriﬁed primary PCR products as template
and +152 Gal-T2 and )59 GalT-2 as set of primers. For mutation of
Ets-1 site, )59/+152 pGL3 was used as DNA template and )59 mEts-1
and +152 Gal-T2 as primers. PCR products were gel-puriﬁed, digested
with XhoI and KpnI and back cloned into the pGL3 basic vector to
generate the )59/+152 mSP1pGL3 and )59/+152 mEts-1pGL3 plas-
mids. Mutations were conﬁrmed by sequence analysis.3. Results
3.1. Deletion analysis and activity of the Gal-T2 promoter
region
Diﬀerent genomic DNA fragments of the 50 upstream region
from the transcription start site [8] of the mouse Gal-T2 gene
were cloned in pGL3 basic reporter vector and transfected to
PC12 cells. A )465/+38 fragment showed about 1500-fold
higher promoter activity than the empty pGL3 (Fig. 1). The
fragment )308/+38 showed a slightly reduced promoter ac-transfected with the indicated DNA fragments from the mouse Gal-T2
gments, as determined by ﬁreﬂy luciferase activity normalized to renilla
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in the region )308/)465. Deletion of 46 bp from the 30 end of
the )308/+38 fragment (clone )308/)9) markedly reduced the
promoter activity, suggesting that cis-acting elements located
in the region )8/+38 are necessary for the basal promoter
activity. On the other hand, deletion of 400 bp of the 50 region
but extending the 30 region to +152 ()59/+152) resulted in a
fragment with about 800-fold activation capacity.
A computerized search (http://www.genomatix.de) for pu-
tative cis-acting elements in the )59/+152 region revealed
binding sites for Brn-2, Ets-1, Staf, Mzf1, Sp1/GC box,
KLF6, and E-box. As in other glycosyltransferases [4], no
TATA box, CAAT or INR sequences were present in this
fragment.Fig. 2. EMSA analyses of protein complexes interacting with the )44/
)12 region. (A) The 50 end 32P labeled )44/)12 oligonucleotide was
incubated without (lane 1) or with 20 g of PC12 extract in the absence
(lane 2) or in the presence of the unlabeled competitor at 10 (lane 3) or
100 (lane 4) molar excess. Competition with two diﬀerent not related
unlabeled oligonucleotides at 100 molar excess (lanes 5 and 6), or with
an oligonucleotide containing a mutation in the Ets-1 motif at 10 (lane
7) and 100 (lane 8) molar excess is also shown. Arrowhead marks the
position of the complex. (B) The 50 end 32P labeled )44/)12 oligonu-
cleotide was incubated without (lane 1) or with 20 lg of PC12 extract
(lane 2), or incubated with anti-Ets-1 antibody in the absence (lane 3)
or presence of 20 lg of PC12 extract (lane 4). As a control of speci-
ﬁcity, the probe was incubated with anti-Sp4 antibody and 20 lg of
PC12 extract (lane 5).3.2. Electrophoretic mobility shift analysis reveals protein
binding to Ets-1 like sites
EMSA experiments with a )44/)12 oligonucleotide as probe
containing a copy of the Ets-1 site at )32/)23 (Fig. 2A) re-
vealed one major complex (lane 2), which was speciﬁcally
competed with a 10- and 100-fold excess of an unlabeled
competitor oligonucleotide with identical sequence (lanes 3
and 4) but not with 100-fold molar excess of unrelated oligo-
nucleotides (lanes 5 and 6). The relevance of the Ets motif
present at )32/)23 was conﬁrmed by mutation of the strin-
gently conserved CCGGAA consensus sequence to AGATCT
(mEts-1). The mutated oligonucleotide was no longer an ef-
fective competitor (lanes 7 and 8), indicating that the Ets-1
sequence was critical for interaction with the protein in the
extract. Fig. 2B shows that complex formation was reduced in
the presence of anti-Ets-1 antibody. Reduction was speciﬁc for
this antibody, since an unrelated antibody (anti-Sp4) was
without eﬀect. No supershifting eﬀect was observed in these
experiments, suggesting failure of binding of the probe to the
antibody-protein complex or of antibody to the protein-oli-
gonucleotide complex. Oligonucleotides containing binding
sites for TFIID, Oct-1, USF1, Sp1, NF-1, c-Myc and SRE
(Fig. 3, lanes 3, 4, 6, 8, 9, 10 and 11) failed to compete. On the
other hand, GABP and PEA3/Ets-1 eﬀectively competed with
the )44/)12 oligonucleotide (Fig. 3, lanes 5 and 7, respec-
tively). These results indicate that the Ets-1 binding site isFig. 3. Competition analyses of protein complex formation with oli-
gonucleotides containing binding sites for various transcription fac-
tors. The oligonucleotide probe containing )44/)12 Gal-T2 sequences
was incubated without (lane 1) or with 20 lg of PC12 extract (lanes 2–
11). In lanes 3–11, the PC12 cell extract was preincubated with unla-
beled oligonucleotides that contain the binding site for TFIID (lane 3),
Oct-1 (lane 4), GABP (lane 5), USF1 (lane 6), PEA3/Ets-1 (lane 7), Sp1
(lane 8), NF-1 (lane 9), c-Myc (lane 10), and SRE (lane 11) tran-
scription factors.
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oligonucleotide.
3.3. Gal-T2 promoter activity increases upon binding of proteins
to the Ets-1 like sequence
To test the functional importance of the Ets binding sites,
the )59/+152 fragment was mutated into the Ets-1 site and
assayed for their promoter activity. A site-speciﬁc mutation in
the Ets-1 site reduced the promoter activity by approximately
90% (Fig. 4), indicating that this site is implicated in the
transcriptional control of mouse Gal-T2 gene expression and
contributes to its basal activity. The relevance of the Ets-1 site
was conﬁrmed by overexpressing the Ets1 transcription factor,
which resulted in a 2.5-fold increase of promoter activity
(Fig. 4).
3.4. Overexpression of Ets-1 in CHO-K1 cells results in
increased expression of complex gangliosides
CHO-K1 cells lack expression of complex gangliosides due
to a lack of GalNAc-T activity. However, stable transfection
of GalNAc-T renders these cells capable of converting a
fraction of GM2 into GD1a, indicating that they express Gal-
T2 and excess of Sial-T4 activities. Transient transfection of
Ets-1 to these cells resulted, after metabolic labeling during 12
h with 14C-galactose (2 lCi), in 11% higher conversion of
GM2 to GD1a, indicating that in transfected cells more gly-
cosylation intermediates were moved downstream the pathway
GM3!GM2!GM1!GD1a (not shown). The simplest in-
terpretation of this result is that overexpression of Ets-1 re-
sulted in increased Gal-T2 activity and hence increased
conversion of intermediates to GD1a.4. Discussion
A 211 bp region ()59/+152) of the proximal promoter of the
mouse Gal-T2 gene characterizes for the absence of typical
mammalian TATA box, CCAAT box or INR (initiator) se-Fig. 4. Functional relevance of Ets-1 site of the )59/+152 fragment.
PC12 cells were transfected with either the wild type )59/+152 lucif-
erase construct (WT) or with the same construct but with the Ets-1 site
mutated (mEts-1), or co-transfected with WT construct and mouse
Ets-1 expressing plasmid pEVRFO Ets-1.quences close to the transcription initiation site and for the
presence of putative sites for interaction with various trans-
acting factors such as Ets-1, Sp1 and Brn-2. A data bank
search revealed conservation of Ets-1, Sp1, and KLF6 binding
sites in putative Gal-T2 promoters of human, rat and mouse.
DNAse I protection and EMSA assays revealed two speciﬁc
DNA-protein complexes. The involved cis-acting sequences
show homology to binding sites for members of the Ets and Sp
transcription factor families. Site directed mutagenesis on the
)59/+152 fragment revealed that the Sp1 sites were of minor
relevance for the functional activity of the promoter (not
shown), while the Ets-1 site at )32/)23 bp (GTCGGC-
TTCCGGCCTAGA) was critical for the promoter activity.
The Ets-1 site is located in a position at which TATA box
elements locate in TATA box containing promoters. It is
noticeable that an Ets-1 element (TASS, GCCGGTTTCCT-
AGA) similarly located was described as important for the
functional activity of the promoter of b1,4 GalT-1 acting on
the synthesis of glycoprotein oligosaccharides and lactose [12].
Transient overexpression of Ets-1 in a CHO-K1 cell clone
expressing low amounts of GD1a increased the synthesis of
this ganglioside by about 11%. Considering an eﬃciency of
transfection of about 30%, this would mean about 33% acti-
vation of GD1a synthesis in the transfected cells, evidence in
favor of the functionality of Ets-1 in vivo. The Ets superfamily
is a structural class of trans-acting phosphoproteins that binds
to purine-rich (GGAA/T) DNA sequences and functions as
transcription factors [13]. Most of the Ets proteins bind DNA
as monomers. However, their transcriptional activity is mod-
ulated by other partner factors [14]. In our case, the Ets site
could play a role in the binding of other proteins necessary for
recruitment and positioning of the transcription initiation
complex [15].
Ets proteins play important roles in diﬀerent biological
processes, including cellular proliferation, diﬀerentiation, de-
velopment, transformation, immune response and apoptosis.
It is interesting to note that particularly Ets-1 increased in
several mouse brain areas during days 7 and 18 of post-natal
development [16], a period characterized for active sinapto-
genesis and synthesis of glycolipids. A concomitant conversion
of simple (GM3, GD3) to complex (GM1, GD1a, GD1b,
GT1b) gangliosides also occurs during this period due to the
upregulation of the activities of GalNAc-T and Gal-T2
transferases, both necessary for synthesis of the tetrasaccharide
chain of complex gangliosides [17].
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